Trastuzumab Recruiting Phase 1 Trials for Healthy Volunteers / Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02057133A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
NCT02581748A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(U.S. and German) in Healthy Chinese Male Subjects